{"id":"W4410822662","doi":"10.1200/jco.2025.43.16_suppl.4501","title":"Avelumab + sacituzumab govitecan (SG) vs avelumab monotherapy as first-line (1L) maintenance treatment in patients (pts) with advanced urothelial carcinoma (aUC): Interim analysis from the JAVELIN Bladder Medley phase 2 trial.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Javelin; Avelumab; Medicine; Urothelial carcinoma; Interim analysis; Metastatic Urothelial Carcinoma; Interim; Internal medicine; Urology; Oncology; Bladder cancer; Clinical trial; Immunotherapy; Cancer; Nivolumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00271787,0.001243025,0.002227403,0.0004566625,0.0003059912,0.00106121,0.0009159156,0.001188781,0.003922199],"category_scores_gemma":[0.001563026,0.0005444402,0.002311134,0.0004517376,0.0006678371,0.0009883266,0.0004375072,0.002789046,0.0007556183],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008727076,"about_ca_system_score_gemma":0.0009753415,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006122534,"about_ca_topic_score_gemma":0.002099601,"domain_scores_codex":[0.9992132,0.0004462214,0.00004435064,0.0001019803,0.00005639785,0.000137957],"domain_scores_gemma":[0.9990025,0.000262702,0.0003135723,0.0001051382,0.00003941058,0.0002767139],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9567223,0.008631563,0.002790801,0.0003646478,0.001552457,0.00005001564,0.00007091079,0.001290245,0.005274409,0.0001031462,0.001266374,0.02188318],"study_design_scores_gemma":[0.5484231,0.4253461,0.0160298,0.00006032405,0.002578835,0.0001975071,0.00005102629,0.001746264,0.003042871,0.0003068103,0.002179823,0.00003750978],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991828,0.002626024,0.000395495,0.0002832212,0.0001498545,0.001229986,0.001730601,0.00008156195,0.00167537],"genre_scores_gemma":[0.9911143,0.001138728,0.00116285,0.0004634601,0.0001612042,0.001633284,0.002258748,0.00002505824,0.002042312],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003922199,"threshold_uncertainty_score":0.0143736,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05185089913416787,"score_gpt":0.4237002166275673,"score_spread":0.3718493174933994,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}